脊髄結核の診断と治療の結果:GeneXpert MTB/RIF,組織病理学,および臨床管理戦略を統合した遡及的研究
Prashant Adhikari1, Isha Amatya2, Pradeep Regmi3
1Hospital for Advanced Medicine and Surgery (HAMS), Kathmandu, Nepal. adhikariprashant@hotmail.com.
まとめ
脊髄結核の治療には抗結核療法 (ATT) が含まれており,重度の変形や神経学的問題には手術が不可欠です. GeneXpert MTB/RIF と組織病理学のような診断ツールを組み合わせることで,脊髄結核 (STB) の症例の精度が向上します.
科学分野:
- 整形外科
- 感染症
- 神経外科
背景:
- 脊髄結核 (STB) は,特に発展途上国において,キフォス性変形および神経学的欠陥を引き起こす重大な病因である.
- STBの効果的な管理戦略は 患者の成果を改善し 長期的な障害を減らすために不可欠です
研究 の 目的:
- 脊髄結核 (STB) の管理における診断,治療,および予後要因を相関させる.
- STBの現在の管理基準の有効性を評価する.
主な方法:
- 2018年から2023年の間に治療されたSTB患者77人を対象とした遡及的研究.
- 診断評価には,GeneXpert MTB/ RIF (GXMTB/ RIF) と組織病理学的生検が含まれていた.
- ビジュアルアナログスケール,オズウェストリー障害指数,炎症マーカー,キフォティック変形,神経学的改善で評価された臨床結果.
主要な成果:
- GeneXpert MTB/ RIFは94. 8%の症例でMycobacterium tuberculosisを検出し,5. 2%がリファンピシン耐性を示した.
- 組織病理学では96. 1%の生検で粒状の浸透が確認され,併用診断の必要性を強調した.
- 93. 5% の患者で正常な神経機能を達成した.
結論:
- 抗結核療法 (ATT) は有効で,手術は重度の変形または神経学的妥協において重要な役割を果たします.
- GXMTB/RIFと組織病理学 (5. 2%) の間の不一致は,臨床判断の重要性を強調しています.
- 手術は STBの治療における 変形矯正と神経学的回復の鍵です
関連する概念動画
Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
Pulmonary Tuberculosis III
439
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
439
Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343


